Loading data for IART — first visit, this takes a few seconds.
Integra LifeSciences Cor... (IART)
: IART
· Echtzeitkurs · USD
n/a
n/a (n/a)
Zum Schluss: Invalid Date
17.24
+0.00%
Nachbörslich: 4:20 PM
Integra LifeSciences Corporation (IART) Stock Price, Analysis & Data
Keine Daten verfügbar
| Geld | n/a |
| Marktkapitalisierung | n/a |
| Umsatz (TTM) | 1.65 Mrd |
| Nettogewinn (TTM) | -7.24 Mio |
| Beta | 1.21 |
| EPS (ttm) | n/a |
| KGV (TTM) | n/a |
| Forward-KGV | 6.62 |
| KBV (TTM) | 1.29 |
| KUV (TTM) | 0.81 |
| Earnings Date | n/a |
| Brief | n/a |
| Volumen | NaN |
| Ø Vol. (20D) | n/a |
| Eröffnung | n/a |
| Vortagesschluss | n/a |
| Tagesspanne | n/a - n/a |
| 52-Wk Range | n/a - n/a |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über IART
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management d...
Branche Medical Devices
Sektor Healthcare
IPO Datum Aug 16, 1995
Mitarbeiter 4,427
Börse NasdaqGS
Tickersymbol IART
Website https://www.integralife.com
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Integra LifeSciences 1.64 Mrd, ein Anstieg von 1.53% im Vergleich zum Vorjahr (1.61 Mrd). Der Gewinn lag bei -516.47 Mio, ein Anstieg von 7,337.7 %.
Finanzberichte